A solution of methylene blue in an erlenmeyer flask. The trending dye was invented by German chemist Heinrich Caro in 1876. Photograph by asikkk, Getty Images If you’ve spotted someone recently with a ...

This vibrantly colored chemical was originally created for use as a fabric dye. Kittisak Kaewchalun via iStock/Getty Images Plus The internet is abuzz with tributes to a liquid chemical called ...

Methylene blue was developed in the 1800s as a cobalt blue synthetic dye for textiles, but it also has some medicinal uses. It's approved to treat a rare blood disorder called methemoglobinemia.

Methylene blue (ProvayBlue) is a medication doctors use to treat a rare blood condition called methemoglobinemia. Naturally, methylene blue is a solid. But as a medical treatment, it’s dissolved in ...

Methylene blue is suddenly everywhere in wellness circles, praised as a brain booster, longevity aid, and even a cellular “reset.” Originally developed as a medical dye more than a century ago, this ...

Methylene blue treats methemoglobinemia, a blood condition. Recently, methylene blue supplements have gained attention for their alleged cognitive and aging support benefits, but these uses require ...

A new social media trend is making headlines: Methylene blue is being touted as a cognitive booster and antiaging miracle. Influencers such as Ben Greenfield are promoting the use of this chemical to ...

Wellness enthusiasts seeking to hack their way to health and longevity have a new favorite remedy — one that stains their tongues blue. Methylene blue has been around since the 1870s when it was used ...

Methylene blue is both a dye and an FDA-approved medication. Described as the first fully synthetic drug used in medicine, methylene blue was initially synthesized by a German chemist in 1876, and 15 ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Lorne J. Hofseth, University of South Carolina (THE CONVERSATION) The internet is ...

Lorne J. Hofseth does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...